Health
FDA Panel Recommends mRNA Flu Vaccine for Older Adults
An FDA advisory panel voted unanimously to recommend Moderna’s mRNA-based flu vaccine for approval, a step closer to making it available to older adults.
Coverage timeline — 1 article
The Hill
A first-of-its-kind flu shot is a step closer to being available to the public after a Food and Drug Administration (FDA) advisory panel voted Thursday to recommend Moderna’s mRNA-based vaccine for approval. The FDA’s independent vaccine advisors voted unanimously 9-0 that the benefits outweigh the
2026-06-18 22:31 UTC